Shirakura S, Karasawa A, Kubo K
Department of Pharmacology, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
Biol Pharm Bull. 1993 May;16(5):475-9. doi: 10.1248/bpb.16.475.
The effect of benidipine on experimental cerebral ischemia was investigated in rats subjected to occlusion of the bilateral common carotid arteries. Benidipine (30 micrograms/kg, i.p.) improved neurological symptoms such as ataxia, convulsion and loss of righting reflex, and prolonged survival time after occlusion of the bilateral common carotid arteries. In the nicardipine (100 micrograms/kg, i.p.)-treated group, a similar effect was observed, whereas nifedipine (100, 300 micrograms/kg, i.p.) and verapamil (300 micrograms/kg, i.p.) did not show any beneficial effect in this model. Furthermore, pretreatment with benidipine (30 micrograms/kg, i.p.) suppressed the increase in cerebral water content 3 h after the occlusion. Nicardipine (100 micrograms/kg, i.p.) showed a tendency to reduce the increase in cerebral water content, though the effect was not statistically significant. Nifedipine (100 micrograms/kg, i.p.) produced no improvement. After occlusion of the bilateral common carotid arteries, depletion of adenosine triphosphate (ATP) and phosphocreatine (CP) and an accumulation of lactate occurred in a time-dependent manner. Prophylactic administration of benidipine (30 micrograms/kg, i.p.), 20 min before occlusion, attenuated the depletion of ATP and CP and the accumulation of lactate 3h after the occlusion. Furthermore, post-treatment with benidipine 30 min after occlusion also suppressed these metabolic disorders. In conclusion, the beneficial effects of benidipine in this severe cerebral ischemia model show that the compound has advantages over nicardipine, nifedipine and verapamil. Thus, these results suggest that benidipine may be useful in the treatment of acute ischemic cerebral damage.
在双侧颈总动脉闭塞的大鼠中研究了贝尼地平对实验性脑缺血的影响。贝尼地平(30微克/千克,腹腔注射)改善了共济失调、惊厥和翻正反射丧失等神经症状,并延长了双侧颈总动脉闭塞后的存活时间。在尼卡地平(100微克/千克,腹腔注射)治疗组中观察到了类似的效果,而硝苯地平(100、300微克/千克,腹腔注射)和维拉帕米(300微克/千克,腹腔注射)在该模型中未显示出任何有益效果。此外,用贝尼地平(30微克/千克,腹腔注射)预处理可抑制闭塞后3小时脑含水量的增加。尼卡地平(100微克/千克,腹腔注射)有降低脑含水量增加的趋势,尽管该效果无统计学意义。硝苯地平(100微克/千克,腹腔注射)未产生改善作用。双侧颈总动脉闭塞后,三磷酸腺苷(ATP)和磷酸肌酸(CP)耗竭以及乳酸蓄积呈时间依赖性发生。在闭塞前20分钟预防性给予贝尼地平(30微克/千克,腹腔注射)可减轻闭塞后3小时ATP和CP的耗竭以及乳酸的蓄积。此外,在闭塞后30分钟用贝尼地平进行治疗也可抑制这些代谢紊乱。总之,贝尼地平在这种严重脑缺血模型中的有益作用表明该化合物优于尼卡地平、硝苯地平和维拉帕米。因此,这些结果提示贝尼地平可能对急性缺血性脑损伤的治疗有用。